Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1986-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.30.6.923PMID 3028253PMCID PMC180620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin

  1986cited by this paper
• Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa

  1984cited by this paper
• Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane

  1984cited by this paper
• Alterations in outer membrane permeability.

  1984cited by this paper
• Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa

  1984cited by this paper
• Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains

  1983cited by this paper
• Polycations sensitize enteric bacteria to antibiotics

  1983cited by this paper
• Electron microscope study of the effect of benzalkonium, chlorhexidine and polymyxin on Pseudomonas cepacia.

  1981cited by this paper
• Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa

  1981cited by this paper
• Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin

  1980cited by this paper
• In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

  1980cited by this paper
• Isolation of atypical lipopolysaccharides from purified cell walls of Pseudomonas cepacia.

  1979cited by this paper
• Function of the Outer Membrane of Escherichia coli as a Permeability Barrier to Beta-Lactam Antibiotics

  1977cited by this paper
• Action of Polymyxin B on Bacterial Membranes: Morphological Changes in the Cytoplasm and in the Outer Membrane of Salmonella typhimurium and Escherichia coli B

  1975cited by this paper
• Action of Polymyxin B on Bacterial Membranes: Morphological Changes in the Cytoplasm and in the Outer Membrane of Salmonella typhimurium and Escherichia coli B

  1975cited by this paper
• Action of Polymyxin B on Bacterial Membranes, I. Binding to the O-Antigenic Lipopolysaccharide of Salmonella typhimurium

  1973cited by this paper

• Cyclopropanation and membrane unsaturation improve antibiotic resistance of swarmer Pseudomonas and its sod mutants exposed to radiations, in vitro and in silico approch

  2024cites this paper
• Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules

  2023cites this paper
• Disparate properties of Burkholderia multivorans and Pseudomonas aeruginosa regarding outer membrane chemical permeabilization to the hydrophobic substances novobiocin and triclosan

  2023influential citation
• Diagnosis and Management of Cystic Fibrosis Exacerbations

  2023cites this paper
• Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients

  2021cites this paper
• Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.

  2021influential citation
• Evaluation of Chemical Changes in Laboratory-Induced Colistin-Resistant Klebsiella pneumoniae

  2021cites this paper
• Acute pulmonary exacerbation in cystic fibrosis

  2020cites this paper
• Bacterial Membrane Vesicles: Biogenesis, Functions and Applications

  2020cites this paper
• Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes

  2020cites this paper
• Whole-genome sequence analysis reveals evolution of antimicrobial resistance in a Ugandan colistin resistant Acinetobacter baumannii

  2020cites this paper
• Biogenesis of Gram-Negative OMVs

  2020cites this paper
• Acute Pulmonary Exacerbations in Cystic Fibrosis

  2019cites this paper
• Twelve Antibiotics for Pseudomonas and Related Infections

  2018cites this paper
• Burkholderia cepacia complex infections: More complex than the bacterium name suggest.

  2018cites this paper
• Virulence capabilities of endemic bacteriophages against Colistin and Extended spectrum beta-lactam resistant non-O157 Escherichia coli strains

  2018cites this paper
• Kolistin, polipeptidni antibiotik zadnje obrane protiv invazivnih Gram-negativnih bakterija

  2018cites this paper
• Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

  2018cites this paper
• Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria

  2017cites this paper
• Gram-negative bacterial membrane vesicle release in response to the host-environment: different threats, same trick?

  2017cites this paper
• Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex

  2017cites this paper
• Burkholderia cepacia Complex Infections Among Cystic Fibrosis Patients: Perspectives and Challenges

  2017cites this paper
• Characterization of Genomic Islands and Mobile Regions of Microbial Genomes in the Context of Infectious Disease

  2016cites this paper
• Lipopolysaccharide Neutralization by Antimicrobial Peptides: A Gambit in the Innate Host Defense Strategy

  2016cites this paper
• Cis-2-Decenoic Acid Interacts with Bacterial Cell Membranes to Potentiate Additive and Synergistic Responses against Biofilm

  2016cites this paper
• Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections

  2015cites this paper
• Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System

  2015cites this paper
• Whole genome sequencing of bacteria in cystic fibrosis as a model for bacterial genome adaptation and evolution

  2014cites this paper
• vietnamiensis to Aminoglycosides Susceptibility of Burkholderia In Vitro

  2014cites this paper
• Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients

  2014cites this paper
• The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity

  2014cites this paper
• Bacterial resistance mechanism: what proteomics can elucidate

  2013cites this paper
• Towards improvement of antibiotic therapy for treating Burkholderia cepacia complex biofilm infections in cystic fibrosis patients

  2013cites this paper
• Antibiotic Resistance in Aquatic Environments of Rio de Janeiro, Brazil

  2013cites this paper
• Screening for a novel antimicrobial interaction for combination therapy

  2013cites this paper
• Multi-Drug and Pan-Drug Resistant Pseudomonas aeruginosa: A Challenge in Post- Antibiotic Era

  2013cites this paper
• Polymyxins and Analogues Bind to Ribosomal RNA and Interfere with Eukaryotic Translation in Vitro

  2013cites this paper
• Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide

  2012cites this paper
• Lipopolysaccharide Neutralization by Antimicrobial Peptides: A Gambit in the Innate Host Defense Strategy

  2012cites this paper
• Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

  2012cites this paper
• Occurrence and antibiotic susceptibility profiles of Burkholderia cepaciacomplex in coastal marine environment

  2012cites this paper
• Studies on the involvement of quorum sensing in the regulation of exopolysaccharide biosynthesis by Burkholderia cepacia complex isolates

  2012cites this paper
• Cationic Peptide and Swarming Motility by a Small Synthetic Inhibition of Bacterial Biofilm Formation

  2012cites this paper
• 156 – Burkholderia cepacia Complex and Other Burkholderia Species

  2012cites this paper
• STUDIES ON THE INVOLVEMENT OF QUORUM SENSING IN THE REGULATION OF EXOPOLYSACCHARIDE BIOSYNTHESIS BY BURKHOLDERIA CEPACIA COMPLEX ISOLATES

  2012cites this paper
• Characterization of a broad host range tailocin from Burkholderia

  2012cites this paper
• AMINOGLYCOSIDE SUSCEPTIBILITY AND ACQUIRED RESISTANCE IN

  2012cites this paper
• Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia

  2011cites this paper
• Identification of Hopanoid Biosynthesis Genes Involved in Polymyxin Resistance in Burkholderia multivorans

  2011cites this paper
• A two-tier model of polymyxin B resistance in Burkholderia cenocepacia.

  2011cites this paper
• Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes

  2011cites this paper
• Antibacterial activity and mechanism of action of chitosan solutions against apricot fruit rot pathogen Burkholderia seminalis.

  2011cites this paper
• Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy

  2011cites this paper
• In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides

  2011cites this paper
• Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium

  2011cites this paper
• Long-Term Colonization of the Cystic Fibrosis Lung by Burkholderia cepacia Complex Bacteria: Epidemiology, Clonal Variation, and Genome-Wide Expression Alterations

  2011cites this paper
• Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia

  2011cites this paper
• Réévaluation de la colistine

  2010cites this paper
• Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa

  2010cites this paper
• Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

  2010cites this paper
• Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence.

  2009cites this paper
• The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients

  2009cites this paper
• Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance.

  2009cites this paper
• Membrane permeability and antimicrobial kinetics of cecropin P1 against Escherichia coli

  2009cites this paper
• The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective

  2009cites this paper
• Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance

  2009cites this paper
• Biosynthesis and Structure of the Burkholderia cenocepacia K56-2 Lipopolysaccharide Core Oligosaccharide

  2009cites this paper
• Bugs, Biofilms, and Resistance in Cystic Fibrosis

  2009cites this paper
• Cystic fibrosis infections: treatment strategies and prospects.

  2009cites this paper
• Universidade Federal do Rio Grande do Sul Faculdade de Medicina Programa de pós-graduação em Medicina: Ciências Médicas Variantes Genômicas do complexo Burkholderia cepacia em Pacientes com Fibrose Cística no Hospital de Clínicas de Porto Alegre

  2009cites this paper
• The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients

  2008cites this paper
• In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species

  2008cites this paper
• Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.

  2008cites this paper
• Emerging and unusual gram-negative infections in cystic fibrosis.

  2007cites this paper
• Analyses of murine beta defensins and defensin inspired peptides

  2007cites this paper
• and pathogenesis Exacerbations in cystic fibrosis · 1: Epidemiology

  2007cites this paper
• Bacterial Resistance to Antimicrobials, Second Edition

  2007cites this paper
• Emerging and Unusual Gram-Negative Infections in Cystic Fibrosis

  2007cites this paper
• Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis

  2007cites this paper
• Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate

  2006cites this paper
• Colistin: the phoenix arises.

  2006cites this paper
• Espèces du complexe Burkholderia cepacia : épidémiologie, pathogénicité et résistance aux antibiotiques

  2006cites this paper
• Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome

  2006cites this paper
• Quinolones Sensitize Gram-Negative Bacteria to Antimicrobial Peptides

  2006cites this paper
• Human beta-defensin-3: a promising antimicrobial peptide.

  2006cites this paper
• Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

  2005cites this paper
• ¡—≈μ‘¥√—° Õ‘ø≈—° ́å ́‘ ‡μ¡ å (Multidrug Efflux Systems; MES): °≈‰°°“√¥◊ÈÕ¬“À≈“¬TMπ‘¥æ√âÕ¡°—π¢Õß·∫§∑’‡√’¬

  2005cites this paper
• The two‐component response regulator PprB modulates quorum‐sensing signal production and global gene expression in Pseudomonas aeruginosa

  2005cites this paper
• Novel agents with inhibitory activity against the Burkholderia cepacia complex

  2005cites this paper
• Class II. Betaproteobacteria class. nov.

  2005cites this paper
• Antibiotic Uptake into Gram-Negative Bacteria

  2005cites this paper
• Identification of bacterial factors associated with the survival of Burkholderia cenocepacia in a murine host

  2004cites this paper
• Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia).

  2004cites this paper
• Review: Lipopolysaccharide of Burkholderia cepacia complex

  2003cites this paper
• Gentamicin Delivery to Burkholderia cepacia Group IIIa Strains via Membrane Vesicles from Pseudomonas aeruginosa PAO1

  2003cites this paper
• Lipopolysaccharide of Burkholderia cepacia complex.

  2003cites this paper
• Regulation of Membrane Permeability by a Two-Component Regulatory System in Pseudomonas aeruginosa

  2003cites this paper
• Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B

  2003cites this paper
• In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex.

  2003cites this paper
• Pathophysiology and management of pulmonary infections in cystic fibrosis.

  2003cites this paper